CYTOKINETICS, INCORPORATED Operating Cash Flow
CYTOKINETICS, INCORPORATED (CYTK) reported Operating Cash Flow of -$305.30 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-06
- CYTOKINETICS, INCORPORATED net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$159.84M.
- CYTOKINETICS, INCORPORATED net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$145.46M.
- CYTOKINETICS, INCORPORATED net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$142.65M.
- CYTOKINETICS, INCORPORATED net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$107.50M.
- CYTOKINETICS, INCORPORATED net cash provided by (used in) operating activities for fiscal 2025 was -$510.01M.
- CYTOKINETICS, INCORPORATED net cash provided by (used in) operating activities for fiscal 2024 was -$395.89M.
- CYTOKINETICS, INCORPORATED net cash provided by (used in) operating activities for fiscal 2023 was -$414.33M.
- CYTOKINETICS, INCORPORATED net cash provided by (used in) operating activities for fiscal 2022 was -$299.52M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 167 month | Net Cash Provided by (Used in) Operating Activities 170 month | Net Cash Provided by (Used in) Operating Activities 173 month | Net Cash Provided by (Used in) Operating Activities 176 month | Net Cash Provided by (Used in) Operating Activities 179 month | Net Cash Provided by (Used in) Operating Activities 182 month | Net Cash Provided by (Used in) Operating Activities 185 month | Net Cash Provided by (Used in) Operating Activities 188 month | Net Cash Provided by (Used in) Operating Activities 191 month | Net Cash Provided by (Used in) Operating Activities 194 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$159.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$305.30M 10-Q · filed 2026-08-06 | -$447.95M derived: sum of 3 quarters · filed 2026-08-06 | -$555.45M derived: sum of 4 quarters · filed 2026-08-06 | ||||||||||
| 2026-03-31 | -$145.46M 10-Q · filed 2026-05-05 | -$288.11M derived: sum of 2 quarters · filed 2026-05-05 | -$395.61M derived: sum of 3 quarters · filed 2026-05-05 | -$523.85M derived: sum of 4 quarters · filed 2026-08-06 | ||||||||||
| 2025-12-31 | -$142.65M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$250.16M derived: sum of 2 quarters · filed 2026-02-26 | -$378.39M derived: sum of 3 quarters · filed 2026-08-06 | -$510.01M 10-K · filed 2026-02-26 | ||||||||||
| 2025-09-30 | -$107.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$235.74M derived: sum of 2 quarters · filed 2026-08-06 | -$367.36M 10-Q · filed 2025-11-05 | -$432.93M derived: sum of 4 quarters · filed 2026-08-06 | ||||||||||
| 2025-06-30 | -$128.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$259.85M 10-Q · filed 2026-08-06 | -$325.42M derived: sum of 3 quarters · filed 2026-08-06 | -$426.92M derived: sum of 4 quarters · filed 2026-08-06 | ||||||||||
| 2025-03-31 | -$131.62M 10-Q · filed 2026-05-05 | -$197.19M derived: sum of 2 quarters · filed 2026-05-05 | -$298.69M derived: sum of 3 quarters · filed 2026-05-05 | -$398.00M derived: sum of 4 quarters · filed 2026-05-05 | ||||||||||
| 2024-12-31 | -$65.57M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$167.07M derived: sum of 2 quarters · filed 2026-02-26 | -$266.38M derived: sum of 3 quarters · filed 2026-02-26 | -$395.89M 10-K · filed 2026-02-26 | ||||||||||
| 2024-09-30 | -$101.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$200.81M derived: sum of 2 quarters · filed 2025-11-05 | -$330.32M 10-Q · filed 2025-11-05 | -$404.36M derived: sum of 4 quarters · filed 2026-02-26 | ||||||||||
| 2024-06-30 | -$99.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$228.82M 10-Q · filed 2025-08-07 | -$302.86M derived: sum of 3 quarters · filed 2026-02-26 | -$399.06M derived: sum of 4 quarters · filed 2026-02-26 | ||||||||||
| 2024-03-31 | -$129.51M 10-Q · filed 2025-05-06 | -$203.54M derived: sum of 2 quarters · filed 2026-02-26 | -$299.75M derived: sum of 3 quarters · filed 2026-02-26 | -$421.55M derived: sum of 4 quarters · filed 2026-02-26 | ||||||||||
| 2023-12-31 | -$74.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$170.24M derived: sum of 2 quarters · filed 2026-02-26 | -$292.05M derived: sum of 3 quarters · filed 2026-02-26 | -$414.33M 10-K · filed 2026-02-26 | ||||||||||
| 2023-09-30 | -$96.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$218.01M derived: sum of 2 quarters · filed 2024-11-07 | -$340.30M 10-Q · filed 2024-11-07 | -$438.49M derived: sum of 4 quarters · filed 2025-02-27 | ||||||||||
| 2023-06-30 | -$121.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | -$244.09M 10-Q · filed 2024-08-09 | -$342.28M derived: sum of 3 quarters · filed 2025-02-27 | -$426.32M derived: sum of 4 quarters · filed 2025-02-27 | ||||||||||
| 2023-03-31 | -$122.29M 10-Q · filed 2024-05-10 | -$220.48M derived: sum of 2 quarters · filed 2025-02-27 | -$304.52M derived: sum of 3 quarters · filed 2025-02-27 | -$394.99M derived: sum of 4 quarters · filed 2025-02-27 | ||||||||||
| 2022-12-31 | -$98.19M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$182.23M derived: sum of 2 quarters · filed 2025-02-27 | -$272.70M derived: sum of 3 quarters · filed 2025-02-27 | -$299.52M 10-K · filed 2025-02-27 | ||||||||||
| 2022-09-30 | -$84.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | -$174.51M derived: sum of 2 quarters · filed 2023-11-03 | -$201.33M 10-Q · filed 2023-11-03 | -$246.06M derived: sum of 4 quarters · filed 2024-02-28 | ||||||||||
| 2022-06-30 | -$90.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$117.29M 10-Q · filed 2023-08-03 | -$162.02M derived: sum of 3 quarters · filed 2024-02-28 | -$200.79M derived: sum of 4 quarters · filed 2024-02-28 | ||||||||||
| 2022-03-31 | -$26.81M 10-Q · filed 2023-05-05 | -$71.55M derived: sum of 2 quarters · filed 2024-02-28 | -$110.32M derived: sum of 3 quarters · filed 2024-02-28 | -$139.81M derived: sum of 4 quarters · filed 2024-02-28 | ||||||||||
| 2021-12-31 | -$44.74M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$83.51M derived: sum of 2 quarters · filed 2024-02-28 | -$113.00M derived: sum of 3 quarters · filed 2024-02-28 | -$142.52M 10-K · filed 2024-02-28 | ||||||||||
| 2021-09-30 | -$38.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | -$68.27M derived: sum of 2 quarters · filed 2022-11-04 | -$97.78M 10-Q · filed 2022-11-04 | -$45.63M derived: sum of 4 quarters · filed 2023-03-01 | ||||||||||
| 2021-06-30 | -$29.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | -$59.02M 10-Q · filed 2022-08-05 | -$6.87M derived: sum of 3 quarters · filed 2023-03-01 | $7.50M derived: sum of 4 quarters · filed 2023-03-01 | ||||||||||
| 2021-03-31 | -$29.52M 10-Q · filed 2022-05-06 | $22.63M derived: sum of 2 quarters · filed 2023-03-01 | $37.00M derived: sum of 3 quarters · filed 2023-03-01 | $9.56M derived: sum of 4 quarters · filed 2023-03-01 | ||||||||||
| 2020-12-31 | $52.15M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $66.52M derived: sum of 2 quarters · filed 2023-03-01 | $39.08M derived: sum of 3 quarters · filed 2023-03-01 | $8.94M 10-K · filed 2023-03-01 | ||||||||||
| 2020-09-30 | $14.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | -$13.07M derived: sum of 2 quarters · filed 2021-11-05 | -$43.21M 10-Q · filed 2021-11-05 | -$62.26M derived: sum of 4 quarters · filed 2022-02-25 | ||||||||||
| 2020-06-30 | -$27.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | -$57.57M 10-Q · filed 2021-08-06 | -$76.63M derived: sum of 3 quarters · filed 2022-02-25 | -$96.90M derived: sum of 4 quarters · filed 2022-02-25 | ||||||||||
| 2020-03-31 | -$30.14M 10-Q · filed 2021-05-07 | -$49.19M derived: sum of 2 quarters · filed 2022-02-25 | -$69.46M derived: sum of 3 quarters · filed 2022-02-25 | -$94.14M derived: sum of 4 quarters · filed 2022-02-25 | ||||||||||
| 2019-12-31 | -$19.05M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | -$39.32M derived: sum of 2 quarters · filed 2022-02-25 | -$64.00M derived: sum of 3 quarters · filed 2022-02-25 | -$90.91M 10-K · filed 2022-02-25 | ||||||||||
| 2019-09-30 | -$20.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | -$44.95M derived: sum of 2 quarters · filed 2020-11-06 | -$71.85M 10-Q · filed 2020-11-06 | -$84.18M derived: sum of 4 quarters · filed 2021-02-26 | ||||||||||
| 2019-06-30 | -$24.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | -$51.58M 10-Q · filed 2020-08-07 | -$63.91M derived: sum of 3 quarters · filed 2021-02-26 | -$96.15M derived: sum of 4 quarters · filed 2021-02-26 | ||||||||||
| 2019-03-31 | -$26.91M 10-Q · filed 2020-05-08 | -$39.23M derived: sum of 2 quarters · filed 2021-02-26 | -$71.47M derived: sum of 3 quarters · filed 2021-02-26 | -$98.31M derived: sum of 4 quarters · filed 2021-02-26 | ||||||||||
| 2018-12-31 | -$12.33M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | -$44.56M derived: sum of 2 quarters · filed 2021-02-26 | -$71.41M derived: sum of 3 quarters · filed 2021-02-26 | -$101.22M 10-K · filed 2021-02-26 | ||||||||||
| 2018-09-30 | -$32.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-01 | -$59.08M derived: sum of 2 quarters · filed 2019-11-01 | -$88.89M 10-Q · filed 2019-11-01 | -$112.96M derived: sum of 4 quarters · filed 2019-11-01 | ||||||||||
| 2018-06-30 | -$26.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | -$56.65M 10-Q · filed 2019-08-09 | -$80.72M derived: sum of 3 quarters · filed 2019-08-09 | -$106.21M derived: sum of 4 quarters · filed 2019-08-09 | ||||||||||
| 2018-03-31 | -$29.81M 10-Q · filed 2019-05-09 | -$53.88M derived: sum of 2 quarters · filed 2019-05-09 | -$79.36M derived: sum of 3 quarters · filed 2019-05-09 | |||||||||||
| 2017-12-31 | -$24.07M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | -$49.55M derived: sum of 2 quarters · filed 2019-03-07 | -$101.76M 10-K · filed 2019-03-07 | |||||||||||
| 2017-09-30 | -$25.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$77.69M 10-Q · filed 2018-11-09 | ||||||||||||
| 2017-06-30 | -$52.20M 10-Q · filed 2018-08-07 | |||||||||||||
| 2014-06-30 | -$9.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$27.20M 10-Q · filed 2014-08-07 | -$39.63M derived: sum of 3 quarters · filed 2014-08-07 | -$29.32M derived: sum of 4 quarters · filed 2014-08-07 | ||||||||||
| 2014-03-31 | -$17.82M 10-Q · filed 2014-05-07 | -$30.25M derived: sum of 2 quarters · filed 2014-05-07 | -$19.94M derived: sum of 3 quarters · filed 2014-05-07 | -$13.32M derived: sum of 4 quarters · filed 2014-08-07 | ||||||||||
| 2013-12-31 | -$12.43M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | -$2.12M derived: sum of 2 quarters · filed 2014-03-07 | $4.50M derived: sum of 3 quarters · filed 2014-08-07 | -$7.72M 10-K · filed 2014-03-07 | ||||||||||
| 2013-09-30 | $10.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06 | $16.93M derived: sum of 2 quarters · filed 2014-08-07 | $4.71M 10-Q · filed 2013-11-06 | -$2.41M derived: sum of 4 quarters · filed 2014-08-07 | -$370.79M 10-Q · filed 2013-11-06 | |||||||||
| 2013-06-30 | $6.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$5.60M 10-Q · filed 2014-08-07 | -$12.72M derived: sum of 3 quarters · filed 2014-08-07 | -$21.60M derived: sum of 4 quarters · filed 2014-08-07 | -$381.09M 10-Q · filed 2013-08-07 | |||||||||
| 2013-03-31 | -$12.22M 10-Q · filed 2014-05-07 | -$19.35M derived: sum of 2 quarters · filed 2014-05-07 | -$28.22M derived: sum of 3 quarters · filed 2014-05-07 | -$36.92M derived: sum of 4 quarters · filed 2014-05-07 | -$387.72M 10-Q · filed 2013-05-08 | |||||||||
| 2012-12-31 | -$7.12M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | -$16.00M derived: sum of 2 quarters · filed 2014-03-07 | -$24.70M derived: sum of 3 quarters · filed 2014-03-07 | -$33.44M 10-K · filed 2014-03-07 | -$375.50M 10-K · filed 2013-03-15 | |||||||||
| 2012-09-30 | -$8.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06 | -$17.58M derived: sum of 2 quarters · filed 2013-11-06 | -$26.31M 10-Q · filed 2013-11-06 | -$37.26M derived: sum of 4 quarters · filed 2014-03-07 | -$368.37M 10-Q · filed 2012-11-07 | |||||||||
| 2012-06-30 | -$8.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | -$17.44M 10-Q · filed 2013-08-07 | -$28.38M derived: sum of 3 quarters · filed 2014-03-07 | -$37.65M derived: sum of 4 quarters · filed 2014-03-07 | -$359.49M 10-Q · filed 2012-08-06 | |||||||||
| 2012-03-31 | -$8.74M 10-Q · filed 2013-05-08 | -$19.68M derived: sum of 2 quarters · filed 2014-03-07 | -$28.95M derived: sum of 3 quarters · filed 2014-03-07 | -$41.45M derived: sum of 4 quarters · filed 2014-03-07 | -$350.80M 10-Q · filed 2012-05-04 | |||||||||
| 2011-12-31 | -$10.95M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | -$20.21M derived: sum of 2 quarters · filed 2014-03-07 | -$32.72M derived: sum of 3 quarters · filed 2014-03-07 | -$45.59M 10-K · filed 2014-03-07 | -$342.06M 10-K · filed 2012-03-13 | |||||||||
| 2011-09-30 | -$9.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | -$21.77M derived: sum of 2 quarters · filed 2012-11-07 | -$34.65M 10-Q · filed 2012-11-07 | -$43.74M derived: sum of 4 quarters · filed 2013-03-15 | -$331.11M 10-Q · filed 2011-11-04 | |||||||||
| 2011-06-30 | -$12.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-06 | -$25.39M 10-Q · filed 2012-08-06 | -$34.48M derived: sum of 3 quarters · filed 2013-03-15 | -$44.79M derived: sum of 4 quarters · filed 2013-03-15 | -$321.85M 10-Q · filed 2011-08-04 | |||||||||
| 2011-03-31 | -$12.88M 10-Q · filed 2012-05-04 | -$21.97M derived: sum of 2 quarters · filed 2013-03-15 | -$32.29M derived: sum of 3 quarters · filed 2013-03-15 | |||||||||||
| 2010-12-31 | -$9.09M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | -$19.41M derived: sum of 2 quarters · filed 2013-03-15 | -$44.83M 10-K · filed 2013-03-15 | |||||||||||
| 2010-09-30 | -$10.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | -$35.74M 10-Q · filed 2011-11-04 | ||||||||||||
| 2010-06-30 | -$25.42M 10-Q · filed 2011-08-04 | |||||||||||||
| 2009-12-31 | $8.42M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |